期刊文献+

经尿道前列腺汽化电切术治疗高危前列腺增生 被引量:7

Transurethral Vaporization for High-Risk Prostate Hyperplasia
下载PDF
导出
摘要 目的探讨经尿道前列腺汽化电切术(transurethral electrovaporization of the prostate,TUVP)治疗高危前列腺增生的安全性和疗效。方法采用经尿道汽化电切术治疗高危前列腺增生90例。结果90例患者平均手术时间54min,全部患者均安全度过围手术期,术后4~5 d拔导尿管,88例排尿通畅,2例拔管后排尿困难,经再次导尿5 d拔管后排尿通畅,无尿失禁及死亡病例。随访1~24个月,国际前列腺症状评分(international prostate symptom score,IPSS)由术前平均31.2分下降至8.6分,生活质量评分(quality of life,QOL)由术前平均5.5分降至2.0分。结论经尿道前列腺汽化电切术治疗高危前列腺增生安全性高,并发症少,疗效满意。 Objective To explore the safety and efficacy of transurethral vaporization of the prostate for benign prostatic hyperplasia with high-risk. Methods Transurethral vaporization of the prostate was performed in 90 patients with high risk of prostate hyperplasia. Results The average operating time was 54 minutes. All patients were safe in the perioperative period. The catheter was pulled away at 4 to 5 days after operation. 88 cases got unobstructed micturition,2 cases received the indwelling urethral catheter again after the first catheterization because of the urination difficulties. No case of urinary incontinence and death was found. A follow-up of 2 to 24 months showed that the international prostate symptom score(IPSS) decreased from 31.2 to 8.6 points, and the score of the quality of life (QOL) decreased from 5.5 to 2.0 points. Conclusions Transurethral vaporization of the prostate is safe and effective with fewer complications for high-risk benign prostatic hyperplasia.
出处 《中华全科医学》 2008年第8期818-819,共2页 Chinese Journal of General Practice
关键词 前列腺增生 经尿道前列腺汽化电切术 Prostatic hyperplasia Transurethral vaporization of the prostate
  • 相关文献

参考文献5

二级参考文献26

  • 1吴开俊.中国人前列腺增生症治疗现状与展望[J].中华泌尿外科杂志,1993,15:12-4.
  • 2王建业 邵鸿勋.TURP术中出血量的测定[J].中华泌尿外科杂志,1990,11:146-147.
  • 3[1]DiTrolio J V. Transurethral ethanol ablation of the prostate, presented AUA 9th annual meeting. March, 1999.
  • 4[2]DiTrolio J V. Chemoablation of the prostate with dehydrated ethanol for treatment of BPH, 5 th International consultation on BPH. June, 2000.
  • 5Carlin BI, Boder DR, Spirnak JP, et al. Role of finasteride in the treatment of recurrent heamaturia secondary to benign prostatic hyperplasia. Prostate, 1997,31 : 180-182.
  • 6Foley SJ,Soloman LZ, Wedderburn AW .et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Uro1,2000,163:436-438.
  • 7Vemeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors:an international consensus on the methodology and criteria of evaluation. Eur J Cancer, 1996,32A : 2474-2484.
  • 8Hahn RG. Dextran 70 and blood loss during transurethral resection of the prostate. Acta Anaes Scand, 1996,40 ;820-823.
  • 9Lekas JM, Widmark BA, Damber JE. Decrement of blood flow preceeds the involution of the ventral prostate in the rat after castration.Urol Res, 1997,25:309-314.
  • 10Takeshita S, Lu Hang, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest, 1994,93:662-665.

共引文献202

同被引文献62

引证文献7

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部